Skip to main content

Table 1 General characteristics of the study population

From: Impact of diabetes and hypertension on cardiovascular outcomes in patients with coronary artery disease receiving percutaneous coronary intervention

 

Study Groups

P value

Control

(N = 359)

DM alone

(N = 178)

HT alone

(N = 382)

DM and HT

(N = 315)

Age (years)

62.1 ± 12.7

62.3 ± 10.8

63.9 ± 11.5

64.4 ± 10.7

0.10

Weight (kg)

66.3 ± 11.7

67.5 ± 13.2

68.5 ± 13.0

68.6 ± 13.8

0.08

Height (cm)

163.1 ± 7.9

161.8 ± 8.7

162.1 ± 8.6

161.9 ± 8.8

0.18

BMI (kg/m2)

24.8 ± 3.5

25.7 ± 4.1

26.0 ± 4.0

26.0 ± 4.0

<0.01

CSP

126.9 ± 20.8

130.0 ± 20.0

141.9 ± 21.6

145.7 ± 25.6

<0.01

CDP

71.8 ± 12.2

70.5 ± 12.4

76.1 ± 13.0

72.8 ± 13.6

<0.01

Cholesterol (mg/dl)

182.7 ± 44.2

171.3 ± 42.2

182.1 ± 42.0

179.1 ± 49.0

0.03

HDL (mg/dl)

41.5 ± 15.8

36.8 ± 14.4

40.2 ± 16.4

37.1 ± 15.4

<0.01

TG (mg/dl)

149.9 ± 110.9

153.8 ± 102.0

155.1 ± 95.1

177.3 ± 121.6

<0.01

LDL (mg/dl)

111.3 ± 39.7

103.8 ± 34.7

110.9 ± 38.2

106.2 ± 39.7

0.07

Serum creatinine (mg/dl)

1.3 ± 1.3

1.8 ± 2.2

1.6 ± 1.9

2.3 ± 2.9

<0.01

Uric acid (mg/dl)

6.6 ± 2.0

6.6 ± 2.2

6.5 ± 2.1

7.2 ± 2.0

0.06

  1. DM alone diabetes alone, HT alone hypertension alone, DM and HT both DM and hypertension, BMI body mass index, Central SP central aortic systolic pressure, Central DP central aortic diastolic pressure, HDL high-density lipoprotein cholesetrol, LDL low- density lipoprotein cholesterol, TG triglyceride